Filter
1704
Filtered Results: 1704
Text search:
diagnóstico
molecular
Featured
Recommendations
199
New Publications
287
Language
Document type
No document type
687
Guidelines
429
Studies & Reports
294
Manuals
118
Strategic & Response Plan
89
Fact sheets
45
Training Material
19
Situation Updates
11
Resource Platforms
6
Infographics
5
Brochures
1
Countries / Regions
India
80
Latin America and the Carribbean
72
Global
63
Western and Central Europe
54
Brazil
53
Africa
35
Eastern Europe
35
Colombia
33
Kenya
25
Argentina
24
Senegal
23
South Africa
23
Peru
21
Tanzania
21
Ethiopia
20
El Salvador
17
West and Central Africa
17
Venezuela
16
Russia
16
Mozambique
15
Germany
15
Congo, Democratic Republic of
15
East and Southern Africa
15
Paraguay
14
Rwanda
12
Chile
11
Malawi
11
Asia
11
South–East Asia Region
11
Zambia
11
Nigeria
10
Bolivia
10
Uganda
10
Sierra Leone
9
Cameroon
9
Philippines
9
Namibia
9
Angola
9
Ecuador
9
Ukraine
8
Ghana
8
Burkina Faso
8
Liberia
8
Bangladesh
7
Zimbabwe
6
Nepal
5
Benin
5
Guinea
5
Eastern Europe and Central Asia
5
France
5
Spain
5
Myanmar / Burma
5
USA
4
Haiti
4
Middle East and North Africa
4
Western Pacific Region
4
North America
4
Côte d’Ivoire / Ivory Coast
4
Indonesia
4
Madagascar
4
Pakistan
4
Cambodia
3
Uruguay
3
Mali
3
Eswatini/ Swaziland
3
Guatemala
3
Thailand
2
Mexico
2
China
2
Syria
2
Congo-Brazzaville
2
Niger
2
Burundi
2
Dominican Republic
2
Guinea-Bissau
2
Lebanon
2
Vietnam
2
Georgia
2
Honduras
2
Chad
2
Tajikistan
1
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Gambia
1
Togo
1
Canada
1
Laos
1
Estonia
1
Morocco
1
Mauritania
1
Italy
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
Turkmenistan
1
Belgium
1
United Kingdom
1
Portugal
1
Nicaragua
1
Djibouti
1
Romania
1
Palestine
1
Central African Republic
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
603
Clinical Guidelines
211
Pharmacy & Technologies
70
Public Health
54
Key Resources
23
Women & Child Health
19
Capacity Building
8
Toolboxes
TB
401
COVID-19
258
NTDs
146
AMR
98
HIV
83
Mental Health
66
Malaria
65
Rapid Response
46
Ebola & Marburg
44
Zika
30
Planetary Health
25
Pharmacy
25
2.0 Rapid Response
21
NCDs
17
Refugee
15
Polio
14
Caregiver
11
Cholera
8
Health Financing Toolbox
8
Specific Hazards
5
Global Health Education
5
Natural Hazards
4
Disability
4
Conflict
3
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
The END TB Strategy
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
Meeting report, 25-26 September 2017 Copenhagen, Denmark
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and WHO technical staff involved in the eradication of yaws.
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
